Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Episode 9 September 01, 2021 00:47:27
Episode 9:  Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP
Few & Far Between: How Biotech Gets Built
Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Sep 01 2021 | 00:47:27

/

Show Notes

Tune in for today's full episode of Few & Far Between. Episode 9 features Biorasi's Becky Knockemus, Zogenix, Inc.'s Dawn Blessing, and J. Michael Graglia from SynGAP Research Fund, discussing the importance of diagnosing #raredisease early and the critical step of sharing study data.

Other Episodes

Episode 56

July 15, 2025 00:39:28
Episode Cover

Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

How do experienced troubleshooters solve a difficult problem? By asking the right questions first! Welcome back to part two of our conversation with Michael...

Listen

Episode 60

September 17, 2025 00:42:11
Episode Cover

Episode 60: Part Two: Yochi Slonim, Co-Founder and CEO at Anima Biotech

Can AI see and talk to human cells? Find out in today's episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien...

Listen

Episode 50

March 18, 2025 00:52:02
Episode Cover

Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova

Now on the Few & Far Between podcast: Did you know that one in ten people with Type 1 Diabetes (TD1) die from hypoglycemia?...

Listen